GSK plc (GSK)

21.00
0.00(0.00%)
  • Volume:
    0
  • Bid/Ask:
    21.00/21.05
  • Day's Range:
    20.48 - 21.06
  • Type:Equity
  • Market:Germany
  • ISIN:GB0009252882
  • WKN:940561

GSK Overview

Prev. Close
20.42
Day's Range
20.48-21.06
Revenue
-
Open
20.48
52 wk Range
15.7-21.77
EPS
-
Volume
0
Market Cap
104.98B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
28,810
P/E Ratio
-
Beta
-
1-Year Change
31.91%
Shares Outstanding
5,061,174,547
Next Earnings Date
-
What is your sentiment on GSK plc?
or
Vote to see community's results!

GSK plc News

GSK plc Analysis

GSK plc Company Profile

GSK plc Company Profile

Employees
90096

GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Lyell Immunopharma, Inc.; Novartis; Sanofi SA; Surface Oncology; Progentec Diagnostics, Inc.; Alector, Inc.; and CureVac AG., as well as strategic partnership with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.

Read More

Technical Summary

Type
Daily
Weekly
Monthly
Moving AveragesStrong BuyStrong BuyStrong Buy
Technical IndicatorsBuyStrong BuyStrong Buy
SummaryStrong BuyStrong BuyStrong Buy
  • The detail above gave me €329k while using his signals
    0
    • This may go up further but I've started to take some profit as precaution. I suspect ulvr may not revise their offer after its sp tanking showing clear sentiments from shareholding to reject this move
      2
      • Moving closer to my 1800 tgt (posted on March 30). This stock pays very generous dividend I have to say
        3
        • ex-div in 13 days time. why risk selling now when you might not get back on the boat? pretty sure the company split will reach equivalent of 2000+ for the two new companies.
          1
          • 1587.80 looking at my previous comment "what do i know" near yearly HIGHS
            0
            • Breakout. Strong buy
              0
              • 1399.60p described as a good Divi stock but where's the potential capital growth... will wait for sub 1200.00p
                2
                • The current CEO seems to have lost confidence, time for a change to inject new life into the company
                  6
                  • the news from today remarked that investors present applauded during the event.
                    0
                  • the question is what percentage of GSK shareholders attended, most big investors gont go to such events
                    0
                  • while true, until we know who attended it's hard to gauge lost confidence. at the start of the day pre share holder day, the share price was 20p down, that swung to 40p up at one point, hardly signals negativity
                    0
                • Seems to me that a stake is being built, especially from the area of £13.25 upwards. We already have the "activist" investment fund but another buyer is around. Seems similar to whats been happening in BT shares over the last few weeks. Stay long and collect dividends on the way. Hopefully
                  1
                  • what will happen when the split happens in 2022?!
                    0
                • MINAYULSK
                  0